Liver Resections for Metastases from Intraabdominal
Leiomyosarcoma by Kalil, Antonio Nocchi et al.
HPB Surgery, 1999, Vol. 11, pp. 261-264
Reprints available directly from the publisher
Photocopying permitted by license only
(C) 1999 OPA (Overseas Publishers Association) N.V.
Published by license under
the Harwood Academic Publishers imprint,
part of The Gordon and Breach Publishing Group.
Printed in Malaysia.
Clinical Series
Liver Resections for Metastases from Intraabdominal
Leiomyosarcoma
ANTONIO NOCCHI KALILa’*, BIANCA DE LOURDES PEREIRA b, MARCIA CRISTINA LIMA BRENNER
b
and LUIZ PEREIRA-LIMA
Associate Professor in the Departament of Surgery of Fundaqo Faculdade Federal de Cincias Mdicas de Porto Alegre (FFFCMPA).
Diplome d’Universit of Hepatobiliary Surgery and Liver Transplants from the University of Paris XI;
b Medical student at FFFCMPA; Full Professor at the FFFCMPA and Associate Professor at Universidade Federal do Rio Grande
do Sul (UFRGS)
This paper discusses liver resection for intraabdomi-
nal leiomyosarcoma metastases as a therapy for
carefully selected patients. Of the 83 hepatectomies
performed from 1992 to 1996, five were resections for
liver metastases due to intraabdominal leiomyosar-
coma, in 3 patients. The surgical indicationwas single
liver metastases, without any evidence of extrahepatic
disease. No mortality occurred during surgery and the
longest survival was 38 months. We concluded that
liver resection for leiomyosarcoma metastases can be
performed, allowing a long term survival in an
occasional patient.
Keywords: Leiomiosarcoma, liver metastases, liver resection,
non-colorectal liver metastases
Metastatic dissemination occurs by haemato-
genous spread, mainly to the lungs and liver,
and only occasionally to regional lymph nodes
[2]. Liver metastases are usually observed in the
reccurrence of visceral and retroperitoneal sar-
comas they are often multiple and bilobar [3, 4].
Some authors suggest that for certain non-
colorectal tumors, including leiomyosarcoma,
the resection of liver metastases might increase
time of survival and/or promote substantial
palliation [5-13].
This paper describes a group of patients with
liver metastases due to leiomyosarcoma.
INTRODUCTION
Leiomyosarcomas are malignant tumors of
smooth muscles, occurring most commonly in
the uterus, retroperitoneal.region and extremi-
ties. These lesions correspond to 7% of the soft
tissue tumors, most often affecting adult, female
patients [1].
PATIENTS AND METHODS
During the period from 1992 to 1997, 83 hepatecto-
mies were performed by a single surgical team in
the Department of Surgery, Fundao Faculdade
Federal de Ci6ncias M6dicas de Porto Alegre
(FFFCMPA). Five of them were liver resections
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for metastases due to leiomyosarcoma, per-
formed in three patients. This group consisted of
two men and one woman whose ages ranged
from 41 to 56 (mean, 46.6), all of them caucasian.
The site of the primary tumor, the time of
diagnosis of liver metastases and their location
are summarized in Table I.
All the patients were submitted to a preopera-
tive assessment which consisted of routine lab
tests, liver function tests and imaging (ultrasono-
graphy-US and computed tomography-CT).
Liver resection was indicated for a single meta-
stasis from leiomyosarcoma, without any evi-
dence of disease at another site.
Hepatectomywas performedby a bilateral sub-
costal incision, with afferent vascular exclusion in
four resections and selective clamping in one
hepatectomy (patient 3, the first resection). Sub-
hepatic silicone drains were used in all patients.
One patient required chest drainage (patient 3).
Surgical mortality was defined by death up to
the 30th day post-surgery. Time of survival was
computed in months (from date of liver resec-
tion up to the latest visit). Reccurrence was
defined by abnormalities in computed tomogra-
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FIGURE Post-resection survival and evolution of liver
metastases due to leiomyosarcoma 1-Patient alive, without
reccurrence at present, after re-hepatectomy at 25months
due to hepatic reccurrence; 2-Died. Extra-hepatic reccurrence
at 4months post-hepatectomy; 3-Died. Submited to re-hepa-
tectomy at 12months due to hepatic reccurrence and, at 24
months, presented new hepatic reccurrence.
is alive and asyrnptomatic, having adjuvant
chemotherapy after the second resection, with
a survival of 37 months.
Left lobectomy was performed in patient 2,
who was submitted to radiation therapy and
chemotherapy five months after liver resection,
due to bone metastasis.
Bi-segrnentectorny was performed in patient
3. He survived for 38 months with reccurrence in
the liver after the second operation.
No mortality occurred in surgery, and the
transfusion of blood products required ranged
from 0 to 1000 ml (mean, 250 rnl).
The presence or absence of reccurrence after liver
resection, the course and survival of patients are
illustrated in Figure 1.
Two segmentectomies were performed in
patient 1. Up to the present time, this patient,
DISCUSSION
An assessment of risk factors for the develop-
ment of metastases due to soft tissue sarcomas
TABLE Study of primary tumor and metastases
Patients Age Site of primary Type of Location of




S.B.* 1) Synchronous 1) Segment V
2) Metachronous 2) Segment VIII
Uterus Metachronous Segments II and III
Stomach 1) Synchronous 1) Segments V and VI
2) Metachronous 2) Segments VII and VIII
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is dependent on 3 factors: histological grade,
histological type and primary tumor site [3].
Leiomyosarcomas constitute 7% of the histo-
logical types, often affecting the uterus, stomach
and small bowel. The most undifferentiated tu-
mors, with the worst prognosis, are found in the
retroperitoneal sites [1, 3].
Recent studies indicate the liver as a prefer-
ential site for metastases from visceral and re-
troperitoneal leiomyosarcomas [3, 4,14]. Most of
these metastases are multiple and bilobar [12],
and 50% of the patients who developed them
did so in the first year after diagnosis. This is the
period during which one must carefully assess
the liver of patients with intra-abdominal leio-
myosarcoma [3,4]. Once the diagnosis of liver
metastases has been established, the type and
histological grade, as well as disease-free time
after resection of the primary tumor do not
appear to influence patient survival [3].
Chemotherapy, systemic or intra-arterial, does
not have a substantial impact on the treatment
of liver metastases from soft tissue sarcomas
[3, 4,15]. However, Mavligit et al. [4] report their
experience with 14 patients who had gastrointes-
tinal leiomyosarcoma, treated by hepatic chemo-
embolization, using a mixture of polyvinyl
alcohol with cisplatinum powder (150mg),
followed by intrahepatic arterial infusion of
vinblastin (10mg/m2). In this series, all the
patients had unresectable liver metastases; how-
ever, one patient had a dramatic regression of
the tumor, which enabled its resection.
From data obtained in series in which the time
of survival after liver resection due to metastases
from leiomyosarcoma was established, a mean
time of 33 months was obtained, one patient pre-
sented a survival longer than 5years [2-16].
Thus, it seems clear that the leiomyosarcomas
constitute an indication for liver resection in the
case of non-colonic metastases.
Based on these findings, we operated on 3
patients with liver metastases from leiomyosar-
coma, and obtained a survival ranging from 24 to
38months. Two patients presented with re-
ccurrence of the disease in the liver, and both of
them were operated on again, corroborating the
data from the literature which reports a high rate
of reccurrence of this type of tumor in the liver
[3, 6,13]. The worst prognosis, was in the case of
the patient with a metastasis of non-digestive
origin, who presented with an extrahepatic
reccurrence less than 6 months after hepatectomy.
Thus, we concluded that the resection of liver
metastases due to leiomyosarcoma could be per-
formed, allowing a long-term survival in an occa-
sional patient.
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resection of metastatic intra-abdominal leiomyo-
sarcoma.A few other authors have reported simi-
lar findings with an occasional 5-year survivor,
althoughnone of 10 patients with liver metastases
from visceral leiomyosarcoma survived for 5
years in the largest single series [1]. It should be
emphasized that spread to the liver is the main
factor determining survival for visceral sarcomas
but not for sarcomas originating at other loca-
tions, with the exception of retroperitoneal
sarcomas that spread as often to the liver as to
the lungs [1]. The pattern of spread, and the
likelihood of having metastases only in the liver,
is of course influenced by the portal venous
drainage of gastrointestinal organs.
Definite indications do not exist, but it would
appear that a patient with isolated and resectable
hepatic metastases from gastrointestinal leiomyo-
sarcoma should undergo resection [2]. A pre-
requisite is that the resection can be undertaken
with low morbidity and low mortality (well
under 5%). Considering the relative inefficiency
of chemotherapy for leiomyosarcoma, it is also
important to be able to ensure clear resection
margins. The difficulty to be confident about
indications and prognostic factors is true for
hepatic resection of all other non-colorectal
secondaries and should, hopefully, lead to an
international registry for patients undergoing
liver resection for non-colorectal secondaries.
INVITED COMMENTARY
The incidence of isolated hepatic metastases
from cancers of the colon or rectum is frequent
enough to justify hepatic resection in selected
patients. For other malignancies metastases to
the liver only is quite a rare phenomen, which
explains why the literature contains relatively
few and almost anecdotal reports of long-term
survival following hepatic resection of meta-
stases from non-colorectal malignancies, such as
intra-abdominal leiomycoscarcoma.
The present study has shown that long-term
survival (at least for 3 years) is possible following
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